NasdaqGS - Nasdaq Real Time Price USD

Anika Therapeutics, Inc. (ANIK)

12.40
+0.55
+(4.64%)
As of 3:35:58 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
117,053
119,907
120,792
113,827
147,794
Cost of Revenue
45,349
43,909
38,260
40,607
64,851
Gross Profit
71,704
75,998
82,532
73,220
82,943
Operating Expense
78,584
81,099
81,688
69,550
101,423
Operating Income
-6,880
-5,101
844
3,670
-18,480
Net Non Operating Interest Income Expense
2,160
2,337
2,312
654
-188
Other Income Expense
--
--
-62,190
--
21,095
Pretax Income
-4,720
-2,764
3,156
4,324
2,427
Tax Provision
6,110
6,064
6,595
2,124
-1,707
Net Income Common Stockholders
-56,744
-56,385
-82,667
-14,859
4,134
Diluted NI Available to Com Stockholders
-56,744
-56,385
-82,667
-14,859
4,134
Basic EPS
-3.86
-3.83
-5.64
-1.02
0.29
Diluted EPS
-3.86
-3.83
-5.64
-1.02
0.28
Basic Average Shares
14,620.75
14,721
14,656
14,561
14,401
Diluted Average Shares
14,620.75
14,721
14,656
14,561
14,634
Total Operating Income as Reported
-6,880
-5,101
844
3,670
2,615
Total Expenses
123,933
125,008
119,948
110,157
166,274
Net Income from Continuing & Discontinued Operation
-56,744
-56,385
-82,667
-14,859
4,134
Normalized Income
-10,830
-8,828
-3,439
2,200
-11,265.35
Net Interest Income
2,160
2,337
2,312
654
-188
EBIT
-6,880
-5,101
844
3,670
-18,480
EBITDA
770
3,020
15,061
18,157
-4,163
Reconciled Cost of Revenue
45,349
43,909
38,260
40,607
64,851
Reconciled Depreciation
7,650
8,121
14,217
14,487
14,317
Net Income from Continuing Operation Net Minority Interest
-10,830
-8,828
-3,439
2,200
4,134
Total Unusual Items Excluding Goodwill
--
--
-62,190
0
21,095
Total Unusual Items
--
--
-62,190
0
21,095
Normalized EBITDA
770
3,020
15,061
18,157
-25,258
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
5,695.65
12/31/2021 - 5/3/1993

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OPTN OptiNose, Inc.
9.46
+0.37%
 
LFCR Lifecore Biomedical, Inc.
6.99
+0.14%
 
COLL Collegium Pharmaceutical, Inc.
29.98
+1.42%
 
ANIP ANI Pharmaceuticals, Inc.
61.65
-1.05%
 
ALKS Alkermes plc
30.97
-0.96%
 
AMRX Amneal Pharmaceuticals, Inc.
7.54
-0.85%
 
KMDA Kamada Ltd.
6.88
+0.88%
 
SUPN Supernus Pharmaceuticals, Inc.
32.28
+0.40%
 
INDV Indivior PLC
11.25
-0.84%
 
EOLS Evolus, Inc.
9.99
+0.10%